Paola Gualtieri

Prof. Paola Gualtieri

Biomedicine and Prevention, University Tor Vergata, Rome, Lazio, Italy
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2019 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
ALAntonino De Lorenzo
Antonino De Lorenzo
SGSanto Gratteri
Santo Gratteri
Paola GualtieriPaola Gualtieri
Paola Gualtieri
ACAndrea Cammarano
Andrea Cammarano
PBPierfrancesco Bertucci
Pierfrancesco Bertucci
Laura Di RenzoLaura Di Renzo
Laura Di Renzo
Obesity must be considered a real pathology. In the world wide, obesity represent one of the major public health issue associated with increased morbidity and mortality. Overweight or obesity, in fact, significantly increases the risk of contracting diseases, such as: arterial hypertension, dyslipidemia, type 2 diabetes mellitus, coronary heart disease, cerebral vasculopathy, gallbladder lithiasis, arthropathy, ovarian polycytosis, sleep apnea syndrome, and some neoplasms. Despite numerous informative campaigns, unfortunately, the fight against obesity does not seem to work: in the last years, the prevalence continued to increase. The progressive and rapid increase in the incidence of obesity, which has characterized most of the economically advanced countries in the last decade, has been the main stimulus for the research of the mechanisms underlying this pathology and the related disorders. The aims of this review is to provide a revision of the literature in order to define obesity as diseases, secondly to highlight the limits and the inaccuracy of common tools used for the diagnosis of obesity, and as a third thing to strengthen the concept of the complexity of obesity as a disease among political health care providers. Obesity may be viewed as a multifactorial pathology and chronic low-grade inflammatory disease. In fact, people affected by obesity have greater risk of developing comorbility and morbility, respect to healthy. Hence, the absolute therapeutic benefit is directly proportional to the basic risk. So, internationally interest on early diagnosis of obesity is growing to avoid under- and overdiagnosis consequences. Therefore, the consequences are an aggravation of the disease and an increase in obesity related pathology like diabetes, cardiovascular disease, and cancer. The most widely used parameter for diagnosis, body mass index (BMI) is not suitable for assessing the body fat. In fact, several studies demonstrate that BMI alone cannot define obesity, which consists not so much in weight gain as in excess fat mass. The use of suitable tools for the assessment of fat mass percentage combined with clinical and genetic analysis allowed to identify different phenotypes of obesity, which explain the various paradoxes of obesity. It is essential to adopt all possible strategies to be able to combat obesity, ameliorate the suffering of patients, and reduce the social and treatment costs of obesity.

19 July 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Laura Di RenzoLaura Di Renzo
Laura Di Renzo
Paola GualtieriPaola Gualtieri
Paola Gualtieri
GCGiulia Cinelli
Giulia Cinelli
GBGiulia Bigioni
Giulia Bigioni
LSLaura Soldati
Laura Soldati
ALAntonino De Lorenzo
Antonino De Lorenzo
The COVID-19 pandemic has had a huge impact on the population with consequences on lifestyles. The aim of the study was to analyse the relationship between eating habits, mental and emotional mood. A survey was conducted online during social isolation, from 24 April to 18 May 2020, among the Italian population. A total of 602 interviewees were included in the data analysis. A high percentage of respondents experienced a depressed mood, anxious feelings, hypochondria and insomnia (61.3%, 70.4%, 46.2% and 52.2%). Almost half of the respondents felt anxious due to the fact of their eating habits, consumed comfort food and were inclined to increase food intake to feel better. Age was inversely related to dietary control (OR = 0.971, p = 0.005). Females were more anxious and disposed to comfort food than males (p < 0.001; p < 0.001). A strength of our study was represented by the fact that the survey was conducted quickly during the most critical period of the Italian epidemic lockdown. As the COVID-19 pandemic is still ongoing, our data need to be confirmed and investigated in the future with larger population studies.

1 March 2020 in Nutrition
Verified
Journal Article
Closed access
ALAntonino De Lorenzo
Antonino De Lorenzo
LRLorenzo Romano
Lorenzo Romano
Laura Di RenzoLaura Di Renzo
Laura Di Renzo
NLNicola Di Lorenzo
Nicola Di Lorenzo
GCGiuseppe Cenname
Giuseppe Cenname
Paola GualtieriPaola Gualtieri
Paola Gualtieri

24 July 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
Laura Di RenzoLaura Di Renzo
Laura Di Renzo
Paola GualtieriPaola Gualtieri
Paola Gualtieri
LRLorenzo Romano
Lorenzo Romano
GMGiulia Marrone
Giulia Marrone
ANAnnalisa Noce
Annalisa Noce
ALAntonino De Lorenzo
Antonino De Lorenzo
Human nutrition is a branch of medicine based on foods biochemical interactions with the human body. The phenotypic transition from health to disease status can be attributed to changes in genes and/or protein expression. For this reason, a new discipline has been developed called “-omic science”. In this review, we analyzed the role of “-omics sciences” (nutrigenetics, nutrigenomics, proteomics and metabolomics) in the health status and as possible therapeutic tool in chronic degenerative diseases. In particular, we focused on the role of nutrigenetics and the relationship between eating habits, changes in the DNA sequence and the onset of nutrition-related diseases. Moreover, we examined nutrigenomics and the effect of nutrients on gene expression. We perused the role of proteomics and metabolomics in personalized nutrition. In this scenario, we analyzed also how dysbiosis of gut microbiota can influence the onset and progression of chronic degenerative diseases. Moreover, nutrients influencing and regulating gene activity, both directly and indirectly, paves the way for personalized nutrition that plays a key role in the prevention and treatment of chronic degenerative diseases.

20 April 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Laura Di RenzoLaura Di Renzo
Laura Di Renzo
Paola GualtieriPaola Gualtieri
Paola Gualtieri
ALAntonino De Lorenzo
Antonino De Lorenzo
Chronic degenerative diseases (CDDs), represented mainly by obesity, cardiovascular disease (CVD), diabetes, chronic kidney disease (CKD), inflammatory bowel diseases, osteoporosis, sarcopenia, neurodegenerative diseases such as Huntington’s disease (HD), rheumatoid arthritis (RA), chronic respiratory diseases, and many cancers, have been, up to now, the most frequent causes of prolonged disability and death worldwide

1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
CCCarmela Colica
Carmela Colica
Laura Di RenzoLaura Di Renzo
Laura Di Renzo
Domenico TrombettaDomenico Trombetta
Domenico Trombetta
Antonella SmeriglioAntonella Smeriglio
Antonella Smeriglio
SBSergio Bernardini
Sergio Bernardini
ALAntonino De Lorenzo
Antonino De Lorenzo
Hydroxytyrosol (HT) plays a significant role in cardiovascular disease (CVD) protection, and its metabolites are able to protect from the endothelial dysfunction commonly present in atherosclerosis. This randomized double‐blinded, placebo‐controlled crossover trial determined the effect in healthy volunteers of two gastroresistant capsules containing 15 mg/day of HT, for a 3‐week period (HTT). Evaluation of nutritional status, serum metabolites, oxidative stress biomarkers, and gene expression of 9 genes related to oxidative stress, inflammation, and CVDs was performed. Oxidation biomarkers like thiol group (p = 0.001), total antioxidant status (TAS) (p = 0.001), superoxide dismutase 1 (SOD1) (2−ΔΔCt = 3.7), and plasma concentration of HT (2.83 μg·mL−1) were significantly increased, while nitrite (p = 0.001), nitrate (p = 0.001), and malondialdehyde (MDA) (p = 0.02) were drastically reduced after HTT. A significant reduction of body fat mass percentage (p = 0.01), suprailiac skinfold (p = 0.01), and weight (p = 0.04; Δ% = −0.46%) was observed after HTT. This study shows that regular intake of 15 mg/day of HT changed body composition parameters and modulated the antioxidant profile and the expression of inflammation and oxidative stress‐related genes. However, it is advisable to personalize HT doses in order to exert its health benefits in CVD prevention and protection of LDL‐C particles from oxidative damage. This trial is registered with ClinicalTrials.gov NCT01890070.